Grindeks

Company based in Riga, Latvia JSC Grindex (branded as Grindex), or simply Grindeks, is an internationally operating Latvian pharmaceutical company with headquarters in Riga, Latvia. Its portfolio consists of original products, generics, and active pharmaceutical ingredients. It mostly focuses on cardiovascular, central nervous system, anti-cancer, and diabetes medicines. Grindex is the leading pharmaceutical manufacturer in the Baltic States. In 2021, Grindex exported products to more than 90 countries. Grindex Group consists of JSC Grindex and its four subsidiaries — JSC Kalceks (Latvia), HBM Pharma Ltd. (Slovakia), JSC Tallinn Pharmaceutical Plant (Estonia) and Namu apsaimniekošanas projekti Ltd. (Latvia). History 1946–1990 Grindex was founded in 1946 when its predecessor, the Vitamin and Hormones Plant, was transformed into an experimental plant to produce medicines. In 1957, the Vitamin and Hormones Plant became part of the newly established Organic Synthesis Institute (OSI). The plant was developed as the OSI's experimental base for the implementation of fundamental research and scientific innovations in manufacturing. By the end of the 1950s, the manufacture of the first